Treatment of children (<15yrs) presenting with a fever of >38 C with intermediate risk/amber symptoms or signs that can be safely managed in the community.

This service aims to improve access to after hours care for children under 14.

Treatment of ingested metal foreign body in children with no red flags i.e. if object is a disc battery, sharp object, object >5cm, multiple magnets.

Treatment of adults with suspicion of pathological fracture where there is no history of injury and children aged 8-16 years for suspicion of SUFE (unexplained hip, or knee pain, especially if the hip is internally rotated and flexed).

General practice plays a critical role in the delivery of childhood immunisations. This funding aims to alleviate some of the administrative burden currently being experienced by general practice and is part of a broader approach to support an increase in completion of 6-week immunisation rates. Please note this funding is available 1 April 2024 to 30 June 2025.

Treatment of children (<15yrs) presenting with a fever of >38 C with intermediate risk/amber symptoms or signs that can be safely managed in the community.

This service aims to improve access to after hours care for children under 14.

Treatment of ingested metal foreign body in children with no red flags i.e. if object is a disc battery, sharp object, object >5cm, multiple magnets.

Treatment of adults with suspicion of pathological fracture where there is no history of injury and children aged 8-16 years for suspicion of SUFE (unexplained hip, or knee pain, especially if the hip is internally rotated and flexed).

General practice plays a critical role in the delivery of childhood immunisations. This funding aims to alleviate some of the administrative burden currently being experienced by general practice and is part of a broader approach to support an increase in completion of 6-week immunisation rates. Please note this funding is available 1 April 2024 to 30 June 2025.

As part of the Rheumatic fever prevention programme, free throat swabs can be offered to eligible populations with suspected Group A streptococcal throat infections.

Treatment of children (<15yrs) presenting with a fever of >38 C with intermediate risk/amber symptoms or signs that can be safely managed in the community.